The cost-effectivness of OM-86 in managing respiratory tract infections in China
Document Type
Article
Publication Date
2015
Abstract
To demonstrate the health economic impact of OM-85, a bacterial lysates based immunostimulant, for approved indications in China
Publication Title
Journal of Medical Economics
Volume
18
Issue
3
First Page
167
Last Page
172
Recommended Citation
Xuan, Jianwei; Wang, Lijie; Yin, Hongjun; Xuan, Dennis; Zhou, Yan; and Hu, Shanlian, "The cost-effectivness of OM-86 in managing respiratory tract infections in China" (2015). PCOM Scholarly Papers. 998.
https://digitalcommons.pcom.edu/scholarly_papers/998
COinS
Comments
This article was published in Journal of Medical Economics, Volume 18, Issue 3, Pages 167-172.
The published version is available at http://dx.doi.org/10.3111/13696998.2014.971159 .Copyright © 2015 Informa.